C4X Discovery Holdings plc (“C4XD”, “C4X Discovery” or the “Company”) Indivior awarded NIH HEAL grant to undertake c
![Indivior Launches National Campaign Informing People of an Additional Treatment for Opioid Use Disorder (OUD) and to Let People with OUD Know That They Can "Keep Moving Towards Recovery" Indivior Launches National Campaign Informing People of an Additional Treatment for Opioid Use Disorder (OUD) and to Let People with OUD Know That They Can "Keep Moving Towards Recovery"](https://storage.googleapis.com/afs-prod/media/5b8679ceb12f621b5a80b204607ca2f9/400.jpeg)
Indivior Launches National Campaign Informing People of an Additional Treatment for Opioid Use Disorder (OUD) and to Let People with OUD Know That They Can "Keep Moving Towards Recovery"
Indivior to Announce Q2/H1 2022 Results and Host Webcast on July 28th Slough, UK, and Richmond, VA, July 7, 2022 – Indivior PL
![AELIS FARMA Announces a Strategic Collaboration and Option-license Agreement With INDIVIOR for the Treatment of Cannabis-related Disorders | Business Wire AELIS FARMA Announces a Strategic Collaboration and Option-license Agreement With INDIVIOR for the Treatment of Cannabis-related Disorders | Business Wire](https://mms.businesswire.com/media/20210608005430/en/883625/23/Aelis_logo.jpg)